New World Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
851
+69
+9% +$70.5K 0.17% 24
2026
Q1
$719K Sell
782
-149
-16% -$151K 0.13% 24
2025
Q4
$1M Buy
931
+78
+9% +$74.6K 0.17% 20
2025
Q3
$651K Sell
853
-108
-11% -$80.4K 0.12% 28
2025
Q2
$749K Sell
961
-117
-11% -$90.9K 0.16% 22
2025
Q1
$890K Buy
1,078
+349
+48% +$290K 0.2% 16
2024
Q4
$563K Buy
729
+328
+82% +$272K 0.14% 27
2024
Q3
$355K Sell
401
-9
-2% -$8.09K 0.09% 44
2024
Q2
$371K Sell
410
-1
-0.2% -$800 0.1% 38
2024
Q1
$320K Buy
411
+2
+0.5% +$1.42K 0.09% 51
2023
Q4
$238K Sell
409
-273
-40% -$159K 0.07% 61
2023
Q3
$366K Buy
682
+192
+39% +$98.9K 0.13% 35
2023
Q2
$230K Sell
490
-483
-50% -$203K 0.08% 53
2023
Q1
$334K Buy
+973
New +$328K 0.13% 44

Other funds holding LLY

New World Advisors's LLY Position: Q2 2026 in Review

New World Advisors increased its Eli Lilly (LLY) stake by 8.8% in Q2 2026, buying an estimated $70.5K and bringing the position to 851 shares worth $1.02M. The position accounts for 0.17% of the portfolio, ranked #24.

New World Advisors first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • New World Advisors held 851 shares of Eli Lilly worth $1.02M as of Q2 2026.
  • New World Advisors bought 69 Eli Lilly shares in Q2 2026, an estimated $70.5K.
  • Eli Lilly made up 0.17% of New World Advisors's portfolio in Q2 2026, its #24 holding.
  • New World Advisors first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on New World Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.